Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
02/03/2010 | EP2149372A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients |
02/03/2010 | EP2148688A1 Treatment of infections by carbon monoxide |
02/03/2010 | EP2148687A2 Topical composition containing sacred water |
02/03/2010 | EP2148572A1 Method for improving the quality of meat by reducing boar taint |
02/03/2010 | EP1078636B1 Pharmaceutical composition for use in emergency treatment and preparation method thereof |
02/03/2010 | CN101641105A Use of arsenic compounds for treatment of pain and inflammation |
02/03/2010 | CN101641104A Therapeutic agent for infectious skin or mucosal disease |
02/02/2010 | US7655717 Ointment composition for treating decubitus ulcers and methods for its making and its use |
02/02/2010 | US7655696 Highly efficacious and highly safe composition of a Stilbene derivative and a platinum coordination compound cis-diaminedichloroplatinum (II) |
02/02/2010 | US7655261 Medicament and method of treatment of patients with heavy metals |
02/02/2010 | US7655260 Antibiotic-free animal feed containing colloidal silver andfish cartilidge powder; health-promoting for livestock including mink, poultry and pigs; plasmacytosis, puppy disease, enteritis virus, three-day sickness and/or "sticky" kits in mink; immunocompetance; veterinary medicine |
02/02/2010 | US7654728 System and method for therapeutic application of dissolved oxygen |
02/02/2010 | CA2477756C Modified phosphocalcic compound, injectable composition containing same |
02/02/2010 | CA2430562C Dna methyl transferase inhibitors |
02/02/2010 | CA2357459C Method for improving bone mineralization |
02/02/2010 | CA2160898C Alimentative infusion liquids for administration through peripheral vein |
01/28/2010 | WO2010011622A2 Ophthalmic gallium compositions and methods of their use |
01/28/2010 | WO2010011533A2 Compositions and methods for increasing serum antioxidant concentrations |
01/28/2010 | WO2010011347A2 Clip inhibitors and methods of modulating immune function |
01/28/2010 | WO2010011343A2 Methods for treating viral disorders |
01/28/2010 | WO2010009739A1 Copper(i)chloride complex of nicotinic acid and pharmaceutical compositions containing the same. |
01/28/2010 | WO2010009589A1 Use of hydrochloric acid for the manufacture of a medicament for treatment of gastritis, enteritis and angiitis |
01/28/2010 | WO2009036877A3 Carbon nanotube powder, carbon nanotube, and method for the production thereof |
01/28/2010 | WO2005102281A3 Porous calcium phosphate networks for synthetic bone material |
01/28/2010 | US20100024072 Methods to Increase Crop Yield |
01/28/2010 | US20100022474 Polymer Controlled Induced Viscosity Fiber System and Uses Thereof |
01/28/2010 | US20100021566 Reverse vitamin k effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets |
01/28/2010 | US20100021564 Om vitamin formula |
01/28/2010 | US20100021563 Compositions comprising coconut oil and methods of use thereof |
01/28/2010 | US20100021562 Self preserved aqueous pharmaceutical compositions |
01/28/2010 | US20100021561 Self-preserved aqueous pharmaceutical compositions |
01/28/2010 | US20100021559 Zeolite supported metallic nanodots |
01/28/2010 | US20100021558 Dilute Aqueous Peracid Solutions and Stabilization Method |
01/28/2010 | US20100021556 Method for the Production of an Agent Against an Infectious Disease |
01/28/2010 | US20100021552 Polysaccharide nanofibers having antimicrobial properties |
01/28/2010 | US20100021545 Injectable in situ self-forming mineral-polymer hybrid composition and uses thereof |
01/28/2010 | US20100021528 Conformable structured therapeutic dressing |
01/28/2010 | US20100021526 Ph modulated films for delivery of actives |
01/28/2010 | US20100021512 Incontinence garments with a silver lining infection stopper |
01/28/2010 | US20100021506 Nitric oxide gel apparatus and method |
01/28/2010 | US20100021464 Methods of wound care and treatment |
01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
01/28/2010 | US20100021426 Methods for making and compositions comprising fermentation products of cordyceps sinensis |
01/28/2010 | US20100021420 Combinations of pyrazole derivatives for the inhibition of cdks and gsk's |
01/28/2010 | US20100021380 Dieghylenetriaminepentaacetic acid (dtpa)-modified ferrofluid, preparation method of the same and uses of the same in preparation of peptide ferrofluid |
01/28/2010 | CA2737146A1 Clip inhibitors and methods of modulating immune function |
01/28/2010 | CA2737144A1 Methods for treating viral disorders |
01/28/2010 | CA2731463A1 Compositions and methods for increasing serum antioxidant concentrations |
01/27/2010 | EP2147676A1 Allergen inactivator |
01/27/2010 | EP2147675A1 Agent for stimulating lymphatic drainage |
01/27/2010 | EP2147005A1 Metal triangulo compound and methods of using the same |
01/27/2010 | CN101636170A Allergen inactivator |
01/27/2010 | CN100584376C Medicine for treating deep erosive trauma with crust |
01/27/2010 | CN100584373C Preparation process of medicine for treating cerebral apoplexy and its sequela |
01/27/2010 | CN100584369C Composition of Chinese traditional medicine for treating rheumatism |
01/27/2010 | CN100584367C Medicine composition for treating fracture and its preparation method |
01/27/2010 | CN100584365C Pharmaceutical composition for treating acne |
01/27/2010 | CN100584360C Chinese medicine composition for treating oral inflammation |
01/27/2010 | CN100584351C Anticancer medicine and its preparation |
01/27/2010 | CN100584340C Medicament for preventing and controlling stomach diseases |
01/27/2010 | CN100584339C Novel use of inorganic carbonate |
01/26/2010 | US7652026 Pharmaceutical composition |
01/26/2010 | US7651974 Adsorbent for oral administration |
01/26/2010 | US7651846 Treatment and diagnosis of conditions associated with elevated arginase activity |
01/26/2010 | US7651704 Use of an aqueous solution in the treatment of live animals |
01/26/2010 | US7651680 Methods and compositions for preventing and treating sensitive and dry skin |
01/26/2010 | US7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
01/21/2010 | WO2010009275A1 Methods of treating inflammation |
01/21/2010 | WO2010009200A2 Methods for treating oral cavity infections with chlorine dioxide |
01/21/2010 | WO2010008976A2 Combined calcium, magnesium and vitamin d supplements |
01/21/2010 | WO2010008519A2 In vitro diagnostic markers comprising carbon nanoparticles and kits |
01/21/2010 | WO2009121600A3 Hydroxytyrosol formulations for the treatment and prevention of dna oxidative damages in post-menopausal conditions |
01/21/2010 | WO2009117387A3 Methods to treat neurodegenerative conditions or diseases by targeting components of a pten signaling pathway |
01/21/2010 | US20100016790 Treatment And Pre-Treatment Device, And Manufacturing Method Therefor, Involving Nitric Oxide |
01/21/2010 | US20100016783 Non-invasive systems and methods for in-situ photobiomodulation |
01/21/2010 | US20100016212 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide |
01/21/2010 | US20100015253 Treatment of nail infections with no |
01/21/2010 | US20100015249 Antitumor agent containing 6'-amidino-2'-naphthyl 4-guanidinobenzoate or salt thereof |
01/21/2010 | US20100015248 Pharmaceutical composition |
01/21/2010 | US20100015247 Carrageenan based antimicrobial compositions |
01/21/2010 | US20100015246 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
01/21/2010 | US20100015244 Nano/Macroporous Bioactive Glasses Made by Melt-Quench Methods |
01/21/2010 | US20100015208 Antibacterial wound dressing |
01/21/2010 | US20100015207 Methods for Treating Oral Cavity Infections with Chlorine Dioxide |
01/21/2010 | US20100015167 in vitro method of screening an individual for metastatic colorectal cancer cells or primary and/or metastatic stomach or esophageal cancer cells; vaccine comprising a protein that comprises human sucrase isomaltase protein |
01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
01/21/2010 | US20100015147 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside |
01/21/2010 | US20100015118 Supplement formula to prevent and deter muscle trauma and method of using same |
01/21/2010 | US20100015115 Compound preparation for quickly reducing oxidative stress and preparation of the same |
01/21/2010 | US20100015097 Method of making sorbent, the sorbent obtained by this method and the uses of the sorbent as feed additive and medicine |
01/21/2010 | US20100015068 Methods and Compositions For Altering Biological Surfaces |
01/21/2010 | US20100012593 Process for treating water |
01/21/2010 | CA2741231A1 Methods for treating oral cavity infections with chlorine dioxide |
01/20/2010 | EP2145617A1 Gel formulation |
01/20/2010 | EP2144616A2 Use of hyperbaric conditions to provide neuroprotection |
01/20/2010 | EP1942914B1 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
01/20/2010 | EP1313422B1 Non-hormonal vaginal contraceptive |
01/20/2010 | EP1204870B1 Method for determining physiological effects of hemoglobin |
01/20/2010 | CN101628008A Nutritional bathing agent |
01/20/2010 | CN101628007A Multi-functional composition for dredging channels and collaterals |